BD & Magnolia Medical Collab to Reduce Blood Culture Contamination
BD and Magnolia Medical Technologies aim to help hospitals reduce blood culture contamination and improve testing accuracy.
BD and Magnolia Medical Technologies aim to help hospitals reduce blood culture contamination and improve testing accuracy.
The FDA has updated its COVID-19 test policy to ensure continued access to tests, transitioning traditional premarket review pathways.
Strategies for properly protecting electronic health data have, by necessity, become a critical part of day-to-day management.
Premier Medical Laboratory Services (PMLS) has received their College of American Pathologists (CAP) Accreditation.
The Centers for Medicare & Medicaid Services issued a proposed rule that would update the CLIA 1988 fee regulations.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
Indiana University Health has opened a bio-secure lab that will be the primary testing site for suspected monkeypox samples in Indiana.
Bruker launched PhenoRisk PACS RuO, a research-use-only NMR test for molecular phenomics research on Long COVID patients’ blood samples.